المؤلفون: Inglis SS; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA., Asleh R; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Iyer VN; Department of Pulmonary and Critical Care Medicine, Mayo Clinic, Rochester, Minnesota, USA., Schettle SD; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Spencer PJ; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Villavicencio MA; Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota, USA., Rodeheffer RJ; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Kushwaha SS; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Behfar A; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA., Rosenbaum AN; Van Cleve Cardiac Regenerative Medicine Program, Mayo Clinic, Rochester, Minnesota, USA.; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota, USA.

المصدر: Artificial organs [Artif Organs] 2024 Jun; Vol. 48 (6), pp. 646-654. Date of Electronic Publication: 2023 Dec 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 7802778 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1525-1594 (Electronic) Linking ISSN: 0160564X NLM ISO Abbreviation: Artif Organs Subsets: MEDLINE

مواضيع طبية MeSH: Heart-Assist Devices*/adverse effects , Gastrointestinal Hemorrhage*/etiology , Gastrointestinal Hemorrhage*/therapy , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/adverse effects , Angiogenesis Inhibitors*/administration & dosage , Pyrimidines*/therapeutic use , Pyrimidines*/adverse effects , Bevacizumab*/therapeutic use , Bevacizumab*/adverse effects , Bevacizumab*/administration & dosage , Sulfonamides*/therapeutic use , Indazoles*/adverse effects , Indazoles*/therapeutic use, Humans ; Male ; Female ; Aged ; Middle Aged ; Retrospective Studies ; Treatment Outcome ; Angiogenesis

المؤلفون: Zhong C; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA. Electronic address: zhongch@mail.uc.edu., Shi Z; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA., Binzel DW; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Jin K; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Li X; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA., Guo P; Center for RNA Nanobiotechnology and Nanomedicine, College of Pharmacy, James Comprehensive Cancer Center, The Ohio State University, Columbus, OH 43210, USA; Dorothy M. Davis Heart and Lung Research Institute, College of Medicine, The Ohio State University, Columbus, OH 43210, USA., Li SK; Division of Pharmaceutical Sciences, James L Winkle College of Pharmacy, University of Cincinnati, Cincinnati, OH 45267, USA.

المصدر: International journal of pharmaceutics [Int J Pharm] 2024 May 25; Vol. 657, pp. 124151. Date of Electronic Publication: 2024 Apr 23.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier/North-Holland Biomedical Press Country of Publication: Netherlands NLM ID: 7804127 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3476 (Electronic) Linking ISSN: 03785173 NLM ISO Abbreviation: Int J Pharm Subsets: MEDLINE

مواضيع طبية MeSH: Nanoparticles*/chemistry , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/chemistry , Vascular Endothelial Growth Factor A* , RNA*/administration & dosage, Animals ; Aptamers, Nucleotide/administration & dosage ; Aptamers, Nucleotide/chemistry ; Humans ; Angiopoietin-2 ; Male ; Mice ; Conjunctiva/metabolism ; Injections, Intraocular ; Cell Proliferation/drug effects ; Neovascularization, Pathologic/drug therapy ; Human Umbilical Vein Endothelial Cells/drug effects ; Retina/metabolism ; Retina/drug effects ; Drug Delivery Systems/methods ; Mice, Inbred C57BL ; Angiogenesis

المؤلفون: Liu S; Department of General Practice, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, No.43 Wuhan Road, Huangshigang District, Huangshi, 435000, Hubei, China., Wei Y; Department of General Practice, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, No.43 Wuhan Road, Huangshigang District, Huangshi, 435000, Hubei, China., Nie L; Department of Abdominal Tumor Surgery, Hubei Province Cancer Hospital, Wuhan, China., Tang Z; Department of Abdominal Oncology, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China., Lu Q; Department of HepatobiliarySurgery, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, Huangshi, China., Liang Q; Department of General Practice, Huangshi Central Hospital, Affiliated Hospital of Hubei Polytechnic University, No.43 Wuhan Road, Huangshigang District, Huangshi, 435000, Hubei, China. 3344871925@qq.com.

المصدر: BMC cancer [BMC Cancer] 2024 May 21; Vol. 24 (1), pp. 614. Date of Electronic Publication: 2024 May 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/drug therapy , Carcinoma, Hepatocellular*/pathology , Carcinoma, Hepatocellular*/metabolism , Liver Neoplasms*/drug therapy , Liver Neoplasms*/pathology , Liver Neoplasms*/metabolism , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/pharmacology , Angiogenic Proteins*/metabolism , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/metabolism, Humans ; Middle Aged ; Male ; Female ; Aged ; Adult ; Lactones/therapeutic use ; Lactones/pharmacology ; Antineoplastic Agents/therapeutic use ; Antineoplastic Agents/pharmacology ; Vascular Endothelial Growth Factor A/metabolism ; Angiogenesis

المؤلفون: Shen Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China., Hou J; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China., Liu W; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China., Lin Z; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China., Ma L; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China., Xu J; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China. Electronic address: xujing611@nankai.edu.cn., Guo Y; State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300350, People's Republic of China; Key Laboratory of Tropical Medicinal Resource Chemistry of Ministry of Education, Hainan Normal University, Haikou, Hainan 571158, People's Republic of China. Electronic address: victgyq@nankai.edu.cn.

المصدر: International journal of biological macromolecules [Int J Biol Macromol] 2024 May; Vol. 267 (Pt 2), pp. 131320. Date of Electronic Publication: 2024 Apr 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0003 (Electronic) Linking ISSN: 01418130 NLM ISO Abbreviation: Int J Biol Macromol Subsets: MEDLINE

مواضيع طبية MeSH: Fungal Polysaccharides*/chemistry , Fungal Polysaccharides*/pharmacology , Fungal Polysaccharides*/isolation & purification , Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/chemistry , Antineoplastic Agents*/isolation & purification , Zebrafish* , Angiogenesis Inhibitors*/pharmacology , Angiogenesis Inhibitors*/chemistry , Angiogenesis Inhibitors*/isolation & purification, Animals ; Humans ; Coriolaceae/chemistry ; Neovascularization, Pathologic/drug therapy ; Vascular Endothelial Growth Factor A/metabolism ; Mice ; Angiogenesis

المؤلفون: Albini A; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Noonan DM; Department of Biotechnology and Life Sciences, University of Insubria, Varese, Italy.; IRCCS MultiMedica, Milan, Italy., Corradino P; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Magnoni F; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy., Corso G; European Institute of Oncologi IEO, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.

المصدر: Cancer prevention research (Philadelphia, Pa.) [Cancer Prev Res (Phila)] 2024 Jul 02; Vol. 17 (7), pp. 289-303.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101479409 Publication Model: Print Cited Medium: Internet ISSN: 1940-6215 (Electronic) Linking ISSN: 19406215 NLM ISO Abbreviation: Cancer Prev Res (Phila) Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/drug therapy , Neoplasms*/prevention & control , Neoplasms*/pathology , Neovascularization, Pathologic*/drug therapy , Neovascularization, Pathologic*/prevention & control , Neovascularization, Pathologic*/pathology , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/pharmacology, Humans ; Animals ; Angiogenesis

المؤلفون: Dou M; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Proteomics, Metabolomics and Drug development core facility, Faculty of Health Sciences, University of Macau, Macau SAR, China., Zhu D; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Cancer Center, Faculty of Health Sciences, University of Macau, Macau, PR China., Cui G; Bioengineering department, Zunyi Medical college, Zhuhai, Guangdong, Province, PR China., Li H; Guang' amen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China., Di L; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Cancer Center, Faculty of Health Sciences, University of Macau, Macau, PR China. Electronic address: lijundi@umac.mo., Wang L; Department of Biological Sciences, Faculty of Health Sciences, University of Macau, Macau, PR China; Institute of Translational Medicine, Faculty of Health Sciences, University of Macau, Macau, PR China; Ministry of Education Frontiers Science Center for Precision Oncology, University of Macau, PR China; Proteomics, Metabolomics and Drug development core facility, Faculty of Health Sciences, University of Macau, Macau SAR, China. Electronic address: liwang@umac.mo.

المصدر: Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2024 Jul; Vol. 129, pp. 155666. Date of Electronic Publication: 2024 Apr 21.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Urban & Fischer Verlag Country of Publication: Germany NLM ID: 9438794 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1618-095X (Electronic) Linking ISSN: 09447113 NLM ISO Abbreviation: Phytomedicine Subsets: MEDLINE

مواضيع طبية MeSH: Euphorbia*/chemistry , Hemangioendothelioma*/drug therapy , Reactive Oxygen Species*/metabolism , Angiogenesis Inhibitors*/pharmacology , Apoptosis*/drug effects , Cell Proliferation*/drug effects , Plant Extracts*/pharmacology , Antineoplastic Agents, Phytogenic*/pharmacology, Animals ; Humans ; Mice ; Cell Line, Tumor ; Melanoma/drug therapy ; Plant Leaves/chemistry ; Melanoma, Experimental/drug therapy ; Neovascularization, Pathologic/drug therapy ; Mice, Inbred C57BL ; Male ; Angiogenesis

المؤلفون: Jasim SA; Medical Laboratory Techniques Department, Al-Maarif University College, Anbar, Iraq., Farber IM; Department of children's diseases of the F. Filatov clinical institute of children's health, I. M. Sechenov First Moscow State Medical University of Health of Russian Federation (Sechenov University), Moscow, Russia., Noraldeen SAM; Department of Oncology and Metabolism, University of Tabuk, Tabuk, Saudi Arabia., Bansal P; Department of Biotechnology and Genetics, Jain (Deemed-to-be) University, Bengaluru, Karnataka 560069, India; Department of Allied Healthcare and Sciences, Vivekananda Global University, Jaipur, Rajasthan 303012, India., Alsaab HO; Department of Pharmaceutics and Pharmaceutical Technology, Taif University, Taif 21944, Saudi Arabia., Abdullaev B; Research Department of Biotechnology, New Uzbekistan University, Mustaqillik Avenue 54, Tashkent 100007, Uzbekistan; Department of Oncology, School of Medicine, Central Asian University, Milliy Bog Street 264, Tashkent 111221, Uzbekistan.. Electronic address: ayntraxt@gmail.com., Alkhafaji AT; Cardiology Department, College of Medicine, Al-Ayen University, Thi-Qar, Iraq., Alawadi AH; College of Technical Engineering, the Islamic University, Najaf, Iraq; College of Technical Engineering, the Islamic University of Al Diwaniyah, Qadisiyyah, Iraq; College of Technical Engineering, the Islamic University of Babylon, Babylon, Iraq., Hamzah HF; Department of Medical Laboratories Technology, AL-Nisour University College, Baghdad, Iraq., Mohammed BA; Department of Technical Engineering, Al-Hadi University College, Baghdad 10011, Iraq.

المصدر: Microvascular research [Microvasc Res] 2024 Jul; Vol. 154, pp. 104691. Date of Electronic Publication: 2024 May 03.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Academic Press Country of Publication: United States NLM ID: 0165035 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-9319 (Electronic) Linking ISSN: 00262862 NLM ISO Abbreviation: Microvasc Res Subsets: MEDLINE

مواضيع طبية MeSH: Neovascularization, Pathologic* , Neoplasms*/therapy , Neoplasms*/immunology , Neoplasms*/blood supply , Neoplasms*/drug therapy , Immunotherapy* , Angiogenesis Inhibitors*, Humans ; Animals ; Tumor Microenvironment ; Nanomedicine ; Antineoplastic Agents, Immunological/administration & dosage ; Antineoplastic Agents, Immunological/therapeutic use ; Angiogenesis

المؤلفون: Xiao T; Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China., Hu S; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Dong S; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Cai Q; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Gong W; Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China., Zhang Y; Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China., Long C; Xiangyang Central Hospital, Affiliated Hospital of Hubei University of Arts and Science, Xiangyang, China., Li X; Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Electronic address: 1219904414@qq.com.

المصدر: International immunopharmacology [Int Immunopharmacol] 2024 Jun 15; Vol. 134, pp. 112144. Date of Electronic Publication: 2024 May 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 100965259 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-1705 (Electronic) Linking ISSN: 15675769 NLM ISO Abbreviation: Int Immunopharmacol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/therapy , Carcinoma, Hepatocellular*/immunology , Carcinoma, Hepatocellular*/mortality , Liver Neoplasms*/therapy , Liver Neoplasms*/immunology , Tumor Microenvironment* , Programmed Cell Death 1 Receptor*/antagonists & inhibitors , Radiofrequency Ablation*/methods , Immune Checkpoint Inhibitors*/therapeutic use , Immune Checkpoint Inhibitors*/pharmacology , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/pharmacology, Animals ; Humans ; Male ; Female ; Combined Modality Therapy ; Mice ; Middle Aged ; Aged ; Phenylurea Compounds/therapeutic use ; Phenylurea Compounds/pharmacology ; Cell Line, Tumor ; Cytokines/metabolism ; Angiogenesis ; Quinolines

المؤلفون: Eberhardt WEE; Department of Medical Oncology, West German Cancer Center, University Medicine Essen, Ruhrlandklinik, Essen, Germany. Electronic address: wilfried.eberhardt@uni-duisburg-essen.de., Sebastian M; Department of Medicin II, Goethe-University Frankfurt, University Hospital, Frankfurt am Main, Germany.

المصدر: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer [J Thorac Oncol] 2024 Jun; Vol. 19 (6), pp. 849-851.

نوع المنشور: Editorial

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 101274235 Publication Model: Print Cited Medium: Internet ISSN: 1556-1380 (Electronic) Linking ISSN: 15560864 NLM ISO Abbreviation: J Thorac Oncol Subsets: MEDLINE

مواضيع طبية MeSH: Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/pharmacology, Humans ; Neovascularization, Pathologic/drug therapy ; Neovascularization, Pathologic/pathology ; Angiogenesis

المؤلفون: Kheraldine H; College of Medicine, QU Health, Qatar University, Doha, Qatar., Hassan AF; College of Pharmacy, QU Health, Qatar University, Doha, Qatar., Alhussain H; Biomedical Research Center, Qatar University, Doha, Qatar., Al-Thawadi H; College of Medicine, QU Health, Qatar University, Doha, Qatar., Vranic S; College of Medicine, QU Health, Qatar University, Doha, Qatar., Al Moustafa AE; College of Medicine, QU Health, Qatar University, Doha, Qatar; Biomedical Research Center, Qatar University, Doha, Qatar; Oncology Department, Faculty of Medicine, McGill University, Montreal, QC, Canada.

المصدر: Biomolecules & biomedicine [Biomol Biomed] 2024 May 02; Vol. 24 (3), pp. 575-581. Date of Electronic Publication: 2024 May 02.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Association of Basic Medical Sciences of FBIH Country of Publication: Bosnia and Herzegovina NLM ID: 9918522188506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2831-090X (Electronic) Linking ISSN: 28310896 NLM ISO Abbreviation: Biomol Biomed Subsets: MEDLINE

مواضيع طبية MeSH: Human Umbilical Vein Endothelial Cells*/drug effects , Quinolines*/pharmacology , Vascular Endothelial Growth Factor A*/metabolism , Vascular Endothelial Growth Factor A*/genetics , Angiogenesis Inhibitors*/pharmacology , Chorioallantoic Membrane*/drug effects , Chorioallantoic Membrane*/blood supply , Neovascularization, Physiologic*/drug effects, Chick Embryo ; Animals ; Humans ; Apoptosis/drug effects ; Fibroblasts/drug effects ; Fibroblasts/metabolism ; Angiogenesis